Istituto Nazionale Tumori IRCCS Fondazione G. Pascale

Naples, Naples 80131

1 studies enrolling now · 3 studies all time

What they study most

Cancer Harboring BRAF Alterations, HGG, LGG, Leiomyosarcoma, Solid Tumors, Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer

Studies at this site

• A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
• Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo) — Running, not enrolling
• Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations — Stopped early